| Quality of life and disease severity in patients with atopic dermatitis JG Holm, T Agner, ML Clausen, SF Thomsen Journal of the European Academy of Dermatology and Venereology 30 (10), 1760 …, 2016 | 128 | 2016 |
| Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre CM Olesen, JG Holm, LB Nørreslet, JV Serup, SF Thomsen, T Agner Journal of the European Academy of Dermatology and Venereology 33 (8), 1562-1568, 2019 | 92 | 2019 |
| Omalizumab for atopic dermatitis: case series and a systematic review of the literature JG Holm, T Agner, C Sand, SF Thomsen International journal of dermatology 56 (1), 18-26, 2017 | 74 | 2017 |
| Dupilumab for prurigo nodularis: case series and review of the literature JG Holm, T Agner, C Sand, SF Thomsen Dermatologic Therapy 33 (2), e13222, 2020 | 56 | 2020 |
| Type 2 diabetes and psoriasis: links and risks JG Holm, SF Thomsen Psoriasis: Targets and Therapy, 1-6, 2019 | 54 | 2019 |
| Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march JG Holm, T Agner, ML Clausen, SF Thomsen Archives of dermatological research 311, 173-182, 2019 | 42 | 2019 |
| Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient‐reported outcomes: a prospective study MN Ghazanfar, JG Holm, SF Thomsen Journal of the European Academy of Dermatology and Venereology 32 (10), 1761 …, 2018 | 41 | 2018 |
| Factors affecting quality of life in patients with hidradenitis suppurativa AHR Jørgensen, JG Holm, MN Ghazanfar, Y Yao, HC Ring, SF Thomsen Archives of Dermatological Research 312, 427-436, 2020 | 38 | 2020 |
| Risk factors for systemic reactions in typical cold urticaria: results from the COLD‐CE study M Bizjak, M Košnik, D Dinevski, SF Thomsen, D Fomina, E Borzova, ... Allergy 77 (7), 2185-2199, 2022 | 29 | 2022 |
| Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence JG Holm, I Ivyanskiy, SF Thomsen Journal of Dermatological Treatment 29 (1), 80-97, 2018 | 28 | 2018 |
| Omalizumab for atopic dermatitis: evidence for and against its use. JG Holm, SF Thomsen Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa …, 2019 | 23 | 2019 |
| Certolizumab pegol for hidradenitis suppurativa: Case report and literature review. JG Holm, AHR Jørgensen, Y Yao, SF Thomsen Dermatologic Therapy 33 (6), 2020 | 19 | 2020 |
| Immunoinflammatory biomarkers in serum are associated with disease severity in atopic dermatitis JG Holm, G Hurault, T Agner, ML Clausen, S Kezic, RJ Tanaka, ... Dermatology 237 (4), 513-520, 2021 | 17 | 2021 |
| Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety AHR Jørgensen, JG Holm, SF Thomsen Clinical Case Reports 8 (12), 2873-2876, 2020 | 17 | 2020 |
| Use of complementary and alternative therapies in outpatients with atopic dermatitis from a dermatological university department JG Holm, ML Clausen, T Agner, SF Thomsen Dermatology 235 (3), 189-195, 2019 | 13 | 2019 |
| Adrenaline autoinjector is underprescribed in typical cold urticaria patients M Bizjak, M Košnik, D Dinevski, SF Thomsen, D Fomina, E Borzova, ... Allergy 77 (7), 2224-2229, 2022 | 9 | 2022 |
| Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature MN Ghazanfar, JG Holm, SF Thomsen Dermatologic Therapy 33 (6), e14010, 2020 | 9 | 2020 |
| Studies on the role of diet in the management of hidradenitis suppurativa are needed HC Eiken, JG Holm, SF Thomsen Journal of the American Academy of Dermatology 82 (4), e137-e138, 2020 | 8 | 2020 |
| Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvement Z Ali, JR Zibert, P Dahiya, CB Johansen, JG Holm, AHR Jørgensen, ... JAAD international 11, 129-136, 2023 | 7 | 2023 |
| Concurrent use of omalizumab and dupilumab in a 47‐year‐old woman with chronic spontaneous urticaria and atopic dermatitis. JG Holm, JA Sørensen, SF Thomsen International Journal of Dermatology 61 (5), 2022 | 5 | 2022 |
